| Views | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 321 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 9 | 11 | 3 | 6 | 2 | 1 | 1 |
| Views | |
|---|---|
| 1065.full.pdf | 173 |
